Health Catalyst Inc [HCAT] stock prices are up 4.80% to $5.89 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HCAT shares have gain 4.62% over the last week, with a monthly amount drifted -20.62%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on January 08, 2025, when KeyBanc Capital Markets upgraded its rating to a Overweight but kept the price target unchanged to $9 for it. Previously, KeyBanc Capital Markets downgraded its rating to Sector Weight on April 10, 2024. On January 03, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $11 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $14 on January 03, 2024. JP Morgan upgraded its rating to a Overweight and reduced its price target to $11 on December 13, 2023. Piper Sandler upgraded its rating to Overweight for this stock on November 13, 2023, and downed its price target to $11. In a note dated August 01, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $16 on this stock.
The stock price of Health Catalyst Inc [HCAT] has been fluctuating between $5.32 and $10.31 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $5.89 at the most recent close of the market. An investor can expect a potential return of 52.8% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
The Health Catalyst Inc [NASDAQ:HCAT] reported sales of 302.06M for trailing twelve months, representing a surge of 3.50%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.21%, Pretax Profit Margin comes in at -0.26%, and Net Profit Margin reading is -0.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.22 and Total Capital is -0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.68 points at the first support level, and at 5.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.00, and for the 2nd resistance point, it is at 6.11.
Ratios To Look Out For
It’s worth pointing out that Health Catalyst Inc [NASDAQ:HCAT]’s Current Ratio is 1.41. Also, the Quick Ratio is 1.41, while the Cash Ratio stands at 1.01. Considering the valuation of this stock, the price to sales ratio is 1.19, the price to book ratio is 1.01.
Transactions by insiders
Recent insider trading involved DANIEL LESUEUR, Officer, that happened on Feb 05 ’25 when 5209.0 shares were purchased. Chief People Officer, Llewelyn Linda completed a deal on Jan 15 ’25 to sell 6442.0 shares. Meanwhile, Officer LINDA LLEWELYN bought 6442.0 shares on Jan 15 ’25.
